Skip to main content
. 2016 Dec 28;8(7):11739–11747. doi: 10.18632/oncotarget.14340

Table 2. Genetic variants of EGLN1/PHD2 gene and the risk of lung cancer.

Patients Controls OR* 95%CI p-Value OR** 95%CI p-Value OR*** 95%CI p-Value
D4E
 Wildtype 174 192 1.00 0.0012 1.00 0.0109 0.0094
 Heterozygous 35 20 2.12 (1.16-3.88) 2.06 (1.13-3.7) 1.91 (1.06-3.5)
 Homozygous 5 1 8.35 (0.82-84.98) 6.74 (0.76-60) 4.97 (0.6-43.5)
 Hetero/Homo 40 21 2.35 (1.31-4.22) 2.26 (1.27-4.0) 2.06 (1.16-3.6)
C127S
 Wildtype 74 101 1.00 0.0002 1.00 0.0018
 Heterozygous 102 94 1.60 (1.05-2.42) 1.52 (1.00-2.3) 1.43 (0.94-2.2) 0.0022
 Homozygous 38 18 3.03 (1.59-5.78) 3.09 (1.62-5.9) 2.75 (1.44-5.2)
 Hetero/homo 140 112 1.83 (1.24-2.72) 1.76 (1.19-2.6) 1.64 (1.1-2.43)
*

adjusting for ethnicity (Tibetan/non-Tibetan)

**

adjusting for religion (Hindu/not Hindu)

***

adjusting for rs142764723 and rs117813469